He Chunhui, Ma Hua
Internal Medicine of Traditional Chinese Medicine.
Medical Image Center, The First Affiliated Hospital of Xinjiang Medical University, Wulumuqi, People's Republic of China.
J Pain Res. 2017 Aug 18;10:1933-1942. doi: 10.2147/JPR.S141607. eCollection 2017.
Plantar heel pain can be managed with dry needling of myofascial trigger points (MTrPs); however, whether MTrP needling is effective remains controversial. Thus, we conducted this meta-analysis to evaluate the effect of MTrP needling in patients with plantar heel pain.
PubMed, Embase, Web of Science, SinoMed (Chinese BioMedical Literature Service System, People's Republic of China), and CNKI (National Knowledge Infrastructure, People's Republic of China) databases were systematically reviewed for randomized controlled trials (RCTs) that assessed the effects of MTrP needling. Pooled weighted mean difference (WMD) with 95% CIs were calculated for change in visual analog scale (VAS) score, and pooled risk ratio (RR) with 95% CIs were calculated for success rate for pain and incidence of adverse events. A fixed-effects model or random-effects model was used to pool the estimates, depending on the heterogeneity among the included studies.
Extensive literature search yielded 1,941 articles, of which only seven RCTs met the inclusion criteria and were included in this meta-analysis. The pooled results showed that MTrP needling significantly reduced the VAS score (WMD =-15.50, 95% CI: -19.48, -11.53; <0.001) compared with control, but it had a similar success rate for pain with control (risk ratio [RR] =1.15, 95% CI: 0.87, 1.51; =0.320). Moreover, MTrP needling was associated with a similar incidence of adverse events with control (RR =1.89, 95% CI: 0.38, 9.39; =0.438).
MTrP needling effectively reduced the heel pain due to plantar fasciitis. However, considering the potential limitations in this study, more large-scale, adequately powered, good-quality placebo-controlled trials are needed to provide more trustworthy evidence in this area.
足底足跟痛可通过肌筋膜触发点(MTrP)干针疗法进行治疗;然而,MTrP针刺是否有效仍存在争议。因此,我们进行了这项荟萃分析,以评估MTrP针刺对足底足跟痛患者的疗效。
系统检索了PubMed、Embase、Web of Science、中国生物医学文献服务系统(SinoMed)和中国知网(CNKI)数据库,查找评估MTrP针刺效果的随机对照试验(RCT)。计算视觉模拟量表(VAS)评分变化的合并加权平均差(WMD)及95%置信区间(CI),计算疼痛成功率和不良事件发生率的合并风险比(RR)及95%CI。根据纳入研究之间的异质性,使用固定效应模型或随机效应模型汇总估计值。
广泛的文献检索共获得1941篇文章,其中只有7项RCT符合纳入标准并被纳入本荟萃分析。汇总结果显示,与对照组相比,MTrP针刺显著降低了VAS评分(WMD = -15.50,95%CI:-19.48,-11.53;P < 0.001),但在疼痛成功率方面与对照组相似(风险比[RR] = 1.15,95%CI:0.87,1.51;P = 0.320)。此外,MTrP针刺与对照组不良事件发生率相似(RR = 1.89,95%CI:0.38,9.39;P = 0.438)。
MTrP针刺可有效减轻足底筋膜炎引起的足跟痛。然而,考虑到本研究存在的潜在局限性,需要更多大规模、有足够效力、高质量的安慰剂对照试验,以在该领域提供更可靠的证据。